来自白树的一氧化氮抑制性瑞香烷二萜类化合物作为阿尔茨海默病潜在的抗神经炎症药物

Nitric oxide inhibitory daphnane diterpenoids as potential anti-neuroinflammatory agents for AD from the twigs of Trigonostemon thyrsoideus.

作者信息

Liu Feng, Yang Xueyuan, Ma Jun, Yang Yuling, Xie Chunfeng, Tuerhong Muhetaer, Jin Da-Qing, Xu Jing, Lee Dongho, Ohizumi Yasushi, Guo Yuanqiang

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, People's Republic of China.

College of Chemistry and Environmental Sciences, Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry, Kashgar University, Kashgar 844000, People's Republic of China.

出版信息

Bioorg Chem. 2017 Dec;75:149-156. doi: 10.1016/j.bioorg.2017.09.007. Epub 2017 Sep 7.

Abstract

The extensive pathology studies revealed that Alzheimer's disease (AD) is closely related to neuroinflammation and anti-neuroinflammatory agents may be potentially useful for the treatment of AD. A continuous search for new nitric oxide (NO) inhibitory compounds as anti-neuroinflammatory agents for AD resulted in the isolation of four new (1-4) and eight known (5-12) daphnane diterpenoids from the twigs of Trigonostemon thyrsoideus. Their structures were elucidated on the basis of extensive nuclear magnetic resonance (NMR) spectroscopic data analysis and the time-dependent density functional theory (TDDFT) electronic circular dichroism (ECD) calculations. Compounds 1-4 represent new examples of daphnane diterpenoid orthoesters and 4 features a rare and complex macroring diterpenoid structure. The anti-neuroinflammatory effects were examined by inhibiting NO release in lipopolysaccharide (LPS)-induced murine microglial BV-2 cells. The possible mechanism of NO inhibition of some bioactive compounds was also investigated using molecular docking, which revealed the interactions of bioactive compounds with the inducible nitric oxide synthase (iNOS) protein.

摘要

广泛的病理学研究表明,阿尔茨海默病(AD)与神经炎症密切相关,抗神经炎症药物可能对AD的治疗具有潜在作用。持续寻找新的一氧化氮(NO)抑制化合物作为AD的抗神经炎症药物,从蜜花三宝木的嫩枝中分离出了4个新的(1 - 4)和8个已知的(5 - 12)瑞香烷二萜类化合物。基于广泛的核磁共振(NMR)光谱数据分析和含时密度泛函理论(TDDFT)电子圆二色性(ECD)计算阐明了它们的结构。化合物1 - 4代表了瑞香烷二萜原酸酯的新例子,化合物4具有罕见且复杂的大环二萜结构。通过抑制脂多糖(LPS)诱导的小鼠小胶质细胞BV - 2细胞中NO的释放来检测抗神经炎症作用。还使用分子对接研究了一些生物活性化合物抑制NO的可能机制,揭示了生物活性化合物与诱导型一氧化氮合酶(iNOS)蛋白的相互作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索